Pharmaceutical Online Videos
-
AGC Biologics Capacity Update February 2024: Cell & Gene
2/28/2024
In this presentation from the February 2024 OPCU event, learn more about the AGC Biologics’ global Cell and Gene network, track record, capabilities, and how it can provide support for any project.
-
ElevateBio Capacity Update February 2024: Cell & Gene
2/28/2024
Explore our facility as we share how our ecosystem brings together R&D, cGMP manufacturing, and groundbreaking technologies to help enhance speed, delivery, and probability of success to support CGTs.
-
Cambrex Capacity Update February 2024: Small Molecule
2/28/2024
Cambrex offers strong expertise in custom development and cGMP API manufacturing for small molecules, including HPAPI, through its Charles City, Iowa facility.
-
Ajinomoto Bio-Pharma Services Capacity Update February 2024: Small Molecule
2/28/2024
Explore the recent expansions of Ajinomoto BPS. Our experts delve into the advancements in our development and manufacturing capabilities for HPAPI, clinical development, and late-stage projects.
-
KBI Biopharma Capacity Update February 2024: Large Molecule
2/28/2024
Learn how KBI Biopharma is equipped to support drug development and biologics manufacturing and accelerate your timeline.
-
BioCentriq Capacity Update February 2024: Cell & Gene
2/27/2024
Learn more about BioCentriq's state-of-the-art facilities, established track record in GMP drug product release, and customized solutions supported by a seasoned team with strong commitment to quality.
-
Forge Biologics Capacity Update February 2024: Cell & Gene
2/27/2024
Explore Forge’s 200,000 square foot, custom-designed cGMP facility dedicated to AAV and plasmid manufacturing.
-
Perform Multiple Chromatography Steps On A Single System
2/26/2024
The Resolute® BioSC platform is a highly modular multi-step chromatography system designed to purify biologics. The platform can be configured to design your own multi-step process.
-
Streamlining Change Control With Unified Quality
2/26/2024
Discover how you can simplify and accelerate the change control process by unifying disconnected quality applications and processes into one innovative platform.
-
FUJIFILM Diosynth Biotechnologies Capacity Update February 2024: Cell & Gene
2/26/2024
Following FUJIFILM's recent investment in cell therapy services, this presentation offers a glimpse into the flexible, smart designs included in the capacity expansion at the Thousand Oaks facility.